Đang chuẩn bị liên kết để tải về tài liệu:
Pathological complete response due to a prolonged time interval between preoperative chemoradiation and surgery in locally advanced rectal cancer: Analysis from the German StuDoQ|Rectalcarcinoma registry

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Preoperative chemoradiotherapy is the recommended standard of care for patients with local advanced rectal cancer. However, it remains unclear, whether a prolonged time interval to surgery results in an increased perioperative morbidity, reduced TME quality or better pathological response. | Pathological complete response due to a prolonged time interval between preoperative chemoradiation and surgery in locally advanced rectal cancer Analysis from the German StuDoQ Rectalcarcinoma registry

TÀI LIỆU LIÊN QUAN

A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy

Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: Retrospective case series

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer

A nomogram based on platelet-tolymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy

Develop and validate a radiomics space-time model to predict the pathological complete response in patients undergoing neoadjuvant treatment of rectal cancer: An artificial intelligence model study based on machine learning

CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients